Influence of age on antileukemic action, subacute toxicity and tissue distribution of ambazone in B6D2F1 mice. 1990

R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
Central Institute of Microbiology and Experimental Therapy, Academy of Sciences of the GDR, Jena.

The influence of age of experimental animals on the antileukemic activity, toxicity and distribution of ambazone, a new potential antineoplastic agent, was studied in 2- and 12-month-old B6D2F1 mice. The predominant effect observed was a significant reduction of the antileukemic action of this compound in old-aged mice. Together with a slight increase in several toxicity parameters this caused a marked reduction of the therapeutic index in 12-month-old mice compared to younger individuals. Furthermore, a general tendency to increased ambazone levels in liver, kidneys and thymus of old-aged mice was observed. Our data therefore provide further evidence that age has to be taken into consideration as one factor that may account for the variety of drug response frequently observed during clinical therapy with anticancer agents.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008935 Mitoguazone Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase. Methylglyoxal Bis(guanylhydrazone),MGBG,Methyl-gag,NSC-32946,Methyl gag,Methylgag,NSC 32946,NSC32946
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females

Related Publications

R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
February 1986, Die Pharmazie,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
May 2024, International journal of biological macromolecules,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
December 1954, Annals of the New York Academy of Sciences,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
March 1969, Cancer research,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
January 2006, Toxicological sciences : an official journal of the Society of Toxicology,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
January 1990, Archiv fur Geschwulstforschung,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
May 1992, Die Pharmazie,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
March 2000, Mechanisms of ageing and development,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
May 1971, European journal of pharmacology,
R Amlacher, and J Baumgart, and A Härtl, and H Weber, and H J Kühnel, and W Schulze, and H Hoffmann
May 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Copied contents to your clipboard!